The IMID Forum

The IMID Forum

Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.

Tämä podcast on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi podcastin jaksot saattavat sisältää mainontaa.

Jaksot(416)

Discussing AxSpA: Risk of Uveitis with Different bDMARDs & PROs following Secukinumab Treatment

Discussing AxSpA: Risk of Uveitis with Different bDMARDs & PROs following Secukinumab Treatment

Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month Dr Sofia Ramiro is joined by Professors Hideto Kameda, Atul Deodhar and Xenofon Barali...

12 Elo 202432min

Discussing RA: March 2024

Discussing RA: March 2024

Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest information and data in rheumatology. In this episode, he discusses ...

12 Elo 20248min

Discussing PsA: Long-term safety of ixekizumab & bimekizumab treatment in a TNFi-IR population

Discussing PsA: Long-term safety of ixekizumab & bimekizumab treatment in a TNFi-IR population

Join Professors Peter Nash, Philip Mease, Frank Behrens, and Laura Coates as they discuss the top publications in the world of PsA. They discuss two highly relevant topics in the field, including the ...

12 Elo 202438min

Discussing AxSpA: Secukinumab retention over time & sacroiliac joint improvements between DMARDs

Discussing AxSpA: Secukinumab retention over time & sacroiliac joint improvements between DMARDs

Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month Dr Sofia Ramiro is joined by Professors Hideto Kameda and Atul Deodhar to discuss the ...

12 Elo 202433min

Discussing PsA: 2023 EULAR recommendations and improvements in PROs with deucravacitinib

Discussing PsA: 2023 EULAR recommendations and improvements in PROs with deucravacitinib

Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, they focus on the updated 2023 EULAR recommendations for PsA and the im...

12 Elo 202428min

Discussing AxSpA: Long-term etanercept response & real-world effectiveness of tofacitinib & adalimumab

Discussing AxSpA: Long-term etanercept response & real-world effectiveness of tofacitinib & adalimumab

Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda, Atul Deodhar and Xenofon Baral...

12 Elo 202429min

IMID Author Interview: Dr Blanca Hernández-Cruz, 2024

IMID Author Interview: Dr Blanca Hernández-Cruz, 2024

Join Professor Peter Nash from the Griffith University in Brisbane, and Blanca Hernández-Cruz, a rheumatologist at Virgen Macarena University Hospital in Seville, as they discuss her recent paper ‘Jan...

12 Elo 202433min

Discussing PsA: Bimekizumab therapy in PsA

Discussing PsA: Bimekizumab therapy in PsA

Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, they focus on the latest publication by Su, et al. and discuss the late...

12 Elo 202429min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
adhd-podi
rss-liian-kuuma-peruna
psykologia
rss-vapaudu-voimaasi
rss-niinku-asia-on
kesken
rss-narsisti
koulu-podcast-2
leikitaanko-laakaria
rahapuhetta
rss-luonnollinen-synnytys-podcast
rss-koira-haudattuna
rss-hereilla
rss-arkea-ja-aurinkoa-podcast-espanjasta
ihminen-tavattavissa-tommy-hellsten-instituutti
rss-psykalab
rss-valo-minussa-2